Dabigatran versus warfarin in patients with mechanical heart valves
Eikelboom, John W × Connolly, Stuart J Brueckmann, Martina Granger, Christopher B Kappetein, Arie P Mack, Michael J Blatchford, Jon Devenny, Kevin Friedman, Jeffrey Guiver, Kelly Harper, Ruth Khder, Yasser Lobmeyer, Maximilian T Maas, Hugo Voigt, Jens-Uwe Simoons, Maarten L Van de Werf, Frans RE-ALIGN Investigators #
New England Journal of Medicine vol:369 issue:13 pages:1206-14
Dabigatran is an oral direct thrombin inhibitor that has been shown to be an effective alternative to warfarin in patients with atrial fibrillation. We evaluated the use of dabigatran in patients with mechanical heart valves.